Branch retinal vein occlusion: Treatment modalities: An update of the literature

Seminars in Ophthalmology

Volumn 29, Issue 2, 2014, Pages 85-107

  Chatziralli, Irini P ^a,b   Jaulim, Adil ^c   Peponis, Vasileios G ^b   Mitropoulos, Panagiotis G ^b   Moschos, Marilita M ^d  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b Specialized Eye Hospital Ophthalmiatrion Athinon   (Greece)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

Anti VEGF; BRVO; Dexamethasone; Laser photocoagulation; Surgical; Triamcinolone

Indexed keywords

ACETYLSALICYLIC ACID; BEVACIZUMAB; CORTICOSTEROID; DALTEPARIN; DEXAMETHASONE; DICLOFENAC; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PARNAPARIN; PEGAPTANIB; RANIBIZUMAB; TICLOPIDINE; TRIAMCINOLONE; TROXERUTIN; VASCULOTROPIN INHIBITOR; DRUG;

ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL MACULAR THICKNESS; CENTRAL RETINAL THICKNESS; DISEASE DURATION; FIBRINOLYSIS; HEMODILUTION; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; LOW LEVEL LASER THERAPY; MULTICENTER STUDY (TOPIC); NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; OPTICAL COHERENCE TOMOGRAPHY; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA DETACHMENT; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; RETINA SURGERY; SHEATHOTOMY; STEROID THERAPY; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE; EYE SURGERY; RETINAL VEIN OCCLUSION;

HUMANS; OPHTHALMOLOGIC SURGICAL PROCEDURES; PHARMACEUTICAL PREPARATIONS; RETINAL VEIN OCCLUSION;

EID: 84896717647     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.3109/08820538.2013.833271     Document Type: Article

References (212)

1. Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: The Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000;98:133-141.
2. Rehak J, Rehak M. Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res 2008;33:111-131.
3. Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994; 117:429-441.
4. Parodi MB, Bandello F. Branch retinal vein occlusion: Classification and treatment. Ophthalmologica 2009; 223(5):298-305.
5. Squizzato A, Manfredi E, Bozzato S, et al. Antithrombotic and fibrinolytic drugs for retinal vein occlusion: A systematic review and a call for action. Thromb Haemost 2010;103:271-276.
6. Houtsmuller AJ, Vermeulen JA, Klompe M, et al. The influence of ticlopidine on the natural course of retinal vein occlusion. Agents Actions Suppl 1984;15:219-229.
7. Glacet-Bernard A, Coscas G, Chabanel A, et al. A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin. Am J Ophthalmol 1994;118:421-429.
8. Kreutzer A, Brunner R, Schäfer HJ, et al. Thrombolytic therapy with recombinant tissue-type plasminogen activator in patients with branch or central vein occlusion of the retina. Fortschr Ophthalmol 1988;85:511-513.
9. Steinkamp GW, Hattenbach LO, Scharrer I, Ohrloff C. Front-loading RT PA thrombolytic therapy in central or venous branch occlusions of the retina. Ophthalmologe 1994; 91:280-282.
10. Weiss JN. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein. Am J Ophthalmol 1998;126:142-144.
11. Hattenbach LO, Steinkamp G, Scharrer I, Ohrloff C. Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion. Ophthalmologica 1998;212:394-398.
12. Hattenbach LO, Friedrich Arndt C, Lerche R, et al. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): A prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion. Retina 2009;29:932-940.
13. Murakami T, Takagi H, Kita M, et al. Intravitreal tissue plasminogen activator to treat macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2006; 142:318-320.
14. Kumagai K, Ogino N, Furukawa M, Larson E. Three treatments for macular edema because of branch retinal vein occlusion: Intravitreous bevacizumab or tissue plasminogen activator, and vitrectomy. Retina 2012;32:520-529.
15. Tagami M, Kusuhara S, Imai H, et al. Impact of intravitreal injection of tissue plasminogen activator on full-field electroretinogram in patients with macular oedema secondary to retinal vein occlusion. Ophthalmologica 2011;226: 81-86.
16. Lazo-Langner A, Hawel J, Ageno W, Kovacs MJ. Low molecular weight heparin for the treatment of retinal vein occlusion: A systematic review and meta-analysis of randomized trials. Haematologica 2010;95:1587-1593.
17. Steigerwalt Jr RD, Cesarone MR, Belcaro G, et al. Retinal and orbital venous occlusions treated with enoxaparin. J Ocul Pharmacol Ther 2008;24:421-426.
18. Farahvash MS, Moradimogadam M, Farahvash MM, et al. Dalteparin versus aspirin in recent-onset branch retinal vein occlusion: A randomized clinical trial. Arch Iran Med 2008;11:418-422.
19. Ageno W, Cattaneo R, Manfredi E, et al. Parnaparin versus aspirin in the treatment of retinal vein occlusion: A randomized, double blind, controlled study. Thromb Res 2010;125:137-141.
20. McIntosh RL, Mohamed Q, Saw SM, Wong TY. Interventions for branch retinal vein occlusion: An evidence- based systematic review. Ophthalmology 2007;114: 835-854.
21. Poupard P, Eledjam JJ, Dupeyron G, et al. Role of acute normovolemic hemodilution in treating retinal venous occlusions. Ann Fr Anesth Reanim 1986;5:229-233.
22. Hansen LL, Wiek J, Arntz R. Randomized study of the effect of isovolemic hemodilution in retinal branch vein occlusion. Fortschr Ophthalmol 1988;85:514-516.
23. Chen HC, Wiek J, Gupta A, et al. Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion. Br J Ophthalmol 1998;82:162-167.
24. Osterloh MD, Charles S. Surgical decompression of branch retinal vein occlusions. Arch Ophthalmol 1988;106: 1469-1471.
25. Opremcak EM, Bruce RA. Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: A prospective review of 15 cases. Retina 1999;19:1-5.
26. Shah GK, Sharma S, Fineman MS, et al. Arteriovenous adventitial sheathotomy for the treatment of macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2000;129:104-106.
27. Le Rouic JF, Bejjani RA, Rumen F, et al. Adventitial sheathotomy for decompression of recent onset branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2001;239:747-751.
28. Dotrelova D, Dubska Z, Kuthan P, Stepankova J. Initial experience with surgical decompression of the vein in branch retinal vein occlusion. Cesk Slov Oftalmol 2001;57: 359-366.
29. Mester U, Dillinger P. Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina 2002;22: 740-746.
30. Cahill MT, Kaiser PK, Sears JE, Fekrat S. The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 2003;87:1329-1332.
31. Becquet F, Le Rouic JF, Zanlonghi X, et al. Efficiency of surgical treatment for chronic macular edema due to branch retinal vein occlusion. J Fr Ophtalmol 2003;26: 570-576.
32. Marti'nez-Soroa I, Ruiz Miguel M, Ostolaza JI, et al. Surgical arteriovenous decompression (sheathotomy) in branch retinal vein occlusion: Retrospective study. Arch Soc Esp Oftalmol 2003;78:603-608.
33. Han DP, Bennett SR, Williams DF, Dev S. Arteriovenous crossing dissection without separation of the retina vessels for treatment of branch retinal vein occlusion. Retina 2003; 23:145-151.
34. Lu L, Li Y, Yi C, et al. Preliminary clinical observation of arteriovenous sheathotomy for treatment of branch retinal vein occlusion. Yan Ke Xue Bao 2003;19:33-38.
35. Fujii GY, de Juan Jr E, Humayun MS. Improvements after sheathotomy for branch retinal vein occlusion documented by optical coherence tomography and scanning laser ophthalmoscope. Ophthalmic Surg Lasers Imaging 2003;34: 49-52.
36. Mason 3rd J, Feist R, White Jr M, et al. Sheathotomy to decompress branch retinal vein occlusion: A matched control study. Ophthalmology 2004;111:540-545.
37. Lerche RC, Richard G. Arteriovenous sheathotomy in venous thrombosis. Klin Monatsbl Augenheilkd 2004;221: 479-484.
38. Asensio Sa'nchez VM, Rodri'guez Bravo I, Botella Oltra G. Adventitial sheathotomy in branch retinal vein occlusion with non ischemic macular edema. Arch Soc Esp Oftalmol 2004;79:347-352.
39. Charbonnel J, Glacet-Bernard A, Korobelnik JF, et al. Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment. Graefes Arch Clin Exp Ophthalmol 2004;242:223-228.
40. Yamamoto S, Saito W, Yagi F, et al. Vitrectomy with or without arteriovenous adventitial sheathotomy for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2004;138:907-914.
41. Garci'a-Arumí J, Martinez-Castillo V, Boixadera A, et al. Management of macular edema in branch retinal vein occlusion with sheathotomy and recombinant tissue plasminogen activator. Retina 2004;24:530-540.
42. Fujimoto R, Ogino N, Kumagai K, et al. The efficacy of arteriovenous adventitial sheathotomy for macular edema in branch retinal vein occlusion. Nihon Ganka Gakkai Zasshi 2004;108:144-149.
43. Lakhanpal RR, Javaheri M, Ruiz-Garcia H, et al. Transvitreal limited arteriovenous-crossing manipulation without vitrectomy for complicated branch retinal vein occlusion using 25-gauge instrumentation. Retina 2005;25: 272-280.
44. Horio N, Horiguchi M. Effect of arteriovenous sheathotomy on retinal blood flow and macular edema in patients with branch retinal vein occlusion. Am J Ophthalmol 2005; 139:739-740.
45. Wrigstad A, Algvere P. Arteriovenous adventitial sheathotomy for branch retinal vein occlusion: Report of a case with longterm follow-up. Acta Ophthalmol Scand 2006;84: 699-702.
46. Feltgen N, Herrmann J, Agostini H, et al. Arterio-venous dissection after isovolaemic haemodilution in branch retinal vein occlusion: A non-randomised prospective study. Graefes Arch Clin Exp Ophthalmol 2006;244:829-835.
47. Sohn JH, Song SJ. Arteriovenous sheathotomy for persistent macular edema in branch retinal vein occlusion. Korean J Ophthalmol 2006;20:210-214.
48. Avci R, Inan UU, Kaderli B. Evaluation of arteriovenous crossing sheathotomy for decompression of branch retinal vein occlusion. Eye 2008;22:120-127.
49. Kumagai K, Furukawa M, Ogino N, et al. Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina 2007; 27:49-54.
50. Crafoord S, Karlsson N, la Cour M. Sheathotomy in complicated cases of branch retinal vein occlusion. Acta Ophthalmol 2008;86:146-150.
51. Chung EJ, Freeman WR, Koh HJ. Visual acuity and multifocal electroretinographic changes after arteriovenous crossing sheathotomy for macular edema associated with branch retinal vein occlusion. Retina 2008;28:220-225.
52. Oh IK, Kim S, Oh J, Huh K. Long-term visual outcome of arteriovenous adventitial sheathotomy on branch retinal vein occlusion induced macular edema. Korean J Ophthalmol 2008;22:1-5.
53. Chung EJ, Lee H, Koh HJ. Arteriovenous crossing sheathotomy versus intravitreal triamcinolone acetonide injection for treatment of macular edema associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2008;246:967-974.
54. Shimura M, Nakazawa T, Yasuda K, et al. Visual prognosis and vitreous cytokine levels after arteriovenous sheathotomy in branch retinal vein occlusion associated with macular oedema. Acta Ophthalmol 2008;86:377-384.
55. Stoffelns BM, Kramann C, Schoepfer K. Arteriovenous crossing sheathotomy in branch retinal vein occlusion. Klin Monbl Augenheilkd 2009;226:310-314.
56. Hwang JC, Gelman SK, Fine HF, et al. Combined arteriovenous sheathotomy and intraoperative intravitreal triamcinolone acetonide for branch retinal vein occlusion. Br J Ophthalmol 2010;94:1483-1489.
57. Muqit MM, Saidkasimova S, Keating D, Murdoch Jr. Long-term study of vascular perfusion effects following arteriovenous sheathotomy for branch retinal vein occlusion. Acta Ophthalmol 2010;88:e57-65.
58. Skevas C, Wagenfeld L, Feucht M, et al. Functional and morphological long-term results after arteriovenous crossing sheathotomy. Acta Ophthalmol 2011;89:e374-375.
59. Amirikia A, Scott IU, Murray TG, et al. Outcomes of vitreoretinal surgery for complications of branch retinal vein occlusion. Ophthalmology 2001;108:372-376.
60. Noma H, Funatsu H, Mimura T, et al. Visual acuity and foveal thickness after vitrectomy for macular edema associated with branch retinal vein occlusion: A case series. BMC Ophthalmol 2010;10:11.
61. TakiW, Oohira A, Hirakata A. Macular edema from distant branch retinal vein occlusion improved after vitrectomy. Jpn J Ophthalmol 2009;53:184-186.
62. Yamasaki M, Noma H, Funatsu H, et al. Changes in foveal thickness after vitrectomy for macular edema with branch retinal vein occlusion and intravitreal vascular endothelial growth factor. Int Ophthalmol 2009;29: 161-167.
63. Kumagai K, Furukawa M, Ogino N, et al. Long-term visual outcomes after vitrectomy for macular edema with foveal hemorrhage in branch retinal vein occlusion. Retina 2007; 27:584-588.
64. Harino S, Bessho K, Kida T. Prospective multicenter study of visual outcomes following three different treatments for macular edema associated with branch retinal vein occlusion: A study by the Japanese BRVO study group. Jpn J Ophthalmol 2012;56:250-261.
65. Sato T, Sawada K, Iwahashi-Shima C, et al. 25-gauge vitrectomy versus intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion: 1 year follow-up. Ann Acad Med Singapore 2012;41:294-299.
66. Noma H, Shimada K, Mimura T. Visual function after pars plana vitrectomy in macular edema with branch retinal vein occlusion. Int Ophthalmol 2013;33:227-236.
67. Stefa'nsson E, Novack RL, Hatchell DL. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 1990;31:284-289.
68. Baharivand N, Hariri A, Javadzadeh A, et al. Pars plana vitrectomy and internal limiting membrane peeling for macular edema secondary to retinal vein occlusion. Clin Ophthalmol 2011;5:1089-1093.
69. Raszewska-Steglinska M, Gozdek P, Cisiecki S, et al. Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol 2009; 19:1055-1062.
70. Arai M, Yamamoto S, Mitamura Y, et al. Efficacy of vitrectomy and internal limiting membrane removal for macular edema associated with branch retinal vein occlusion. Ophthalmologica 2009;223:172-176.
71. Mandelcorn MS, Nrusimhadevara RK. Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: A report of 14 cases. Retina 2004;24: 348-355.
72. Ma J, Yao K, Zhang Z, Tang X. 25-gauge vitrectomy and triamcinolone acetonide-assisted internal limiting membrane peeling for chronic cystoid macular edema associated with branch retinal vein occlusion. Retina 2008; 28:947-956.
73. Uemura A, Yamamoto S, Sato E, et al. Vitrectomy alone versus vitrectomy with simultaneous intravitreal injection of triamcinolone for macular edema associated with branch retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2009;40:6-12.
74. Hirano Y, Sakurai E, Yoshida M, Ogura Y. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion. Ophthalmic Res 2007;39:207-212.
75. Udaondo P, Di'az-Llopis M, Garci'a-Delpech S, et al. Intravitreal plasmin without vitrectomy for macular edema secondary to branch retinal vein occlusion. Arch Ophthalmol 2011;129:283-287.
76. Tsujikawa A, Fujihara M, Iwawaki T, et al. Triamcinolone acetonide with vitrectomy for treatment of macular edema associated with branch retinal vein occlusion. Retina 2005; 25:861-867.
77. Wetzig PC. The treatment of acute branch vein occlusion by photocoagulation. Trans Am Ophthalmol Soc 1978;76: 654-669.
78. Shilling JS, Jones CA. Retinal branch vein occlusion: A study of argon laser photocoagulation in the treatment of macular oedema. Br J Ophthalmol 1984;68:196-198.
79. Gutman FA, Zegarra H, Rauer A, Zakov N. Photocoagulation in retinal branch vein occlusion. Trans Am Ophthalmol Soc 1980;78:156-166.
80. Jalkh AE, Avila MP, Zakka KA, et al. Chronic macular edema in retinal branch vein occlusion: Role of laser photocoagulation. Ann Ophthalmol 1984;16:526-529.
81. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984;98:271-282.
82. Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Arch Ophthalmol 1986;104:34-41.
83. Finkelstein D. Argon laser photocoagulation for macular edema in branch vein occlusion. Ophthalmology 1986;93: 975-977.
84. Gaudric A, Giorgi F, Sterkers M, et al. Photocoagulation with the argon laser in cystoid macular edema in retinal venous occlusions: Apropos of 68 cases. J Fr Ophtalmol 1988;11:319-326.
85. Reha'k J, Vymazal M. Treatment of branch retinal vein occlusion with argon laser photocoagulation. Acta Univ Palacki Olomuc Fac Med 1989;123:231-236.
86. Bouzikas SP, Tsirou M, Economidis I, Pollalis SP. Argon-green laser photocoagulation in the treatment of cystoid macular edema secondary to branch vein occlusion. J Fr Ophtalmol 1989;12:909-914.
87. Battaglia Parodi M, Saviano S, Ravalico G. Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 1999;237:1024-1027.
88. Battaglia Parodi M, Saviano S, Bergamini L, Ravalico G. Grid laser treatment of macular edema in macular branch retinal vein occlusion. Doc Ophthalmol 1999;97: 427-431.
89. Scott IU, VanVeldhuisen PC, Oden NL, et al. SCORE Study report 1: Baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. Ophthalmology 2009;116:504-512.
90. Scott IU, Ip MS, VanVeldhuisen PC, et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: The Standard Care versus Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol 2009;127:1115-1128.
91. Hayreh SS, Rubenstein L, Podhajsky P. Argon laser scatter photocoagulation in treatment of branch retinal vein occlusion: A prospective clinical trial. Ophthalmologica 1993;206:1-14.
92. Pitcher 3rd JD, Liu T, Prasad PS, et al. Short-duration focal pattern grid photocoagulation for macular edema secondary to branch retinal vein occlusion. Semin Ophthalmol 2012;27:69-72.
93. Soheilian M, Karimi S, Ramezani A, Peyman GA. Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies. Retina 2010;30: 509-515.
94. Coscas G, Loewenstein A, Augustin A, et al. Management of retinal vein occlusion-consensus document. Ophthalmologica 2011;226:4-28.
95. Lattanzio R, Torres Gimeno A, Battaglia Parodi M, et al. Retinal vein occlusion: Current treatment. Ophthalmologica 2011;225:135-143.
96. Degenring RF, Kamppeter B, Kreissig I, Jonas JB. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion. Acta Ophthalmol Scand 2003;81:548-550.
97. Wakabayashi T, Okada AA, Morimura Y, et al. Transtenon retrobulbar triamcinolone infusion for chronic macular edema in central and branch retinal vein occlusion. Retina 2004;24:964-967.
98. Chen SD, Lochhead J, Patel CK, Frith P. Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion. Br J Ophthalmol 2004;88:154-155.
99. Yepremyan M, Wertz FD, Tivnan T, et al. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging 2005;36:30-36.
100. Chen SD, Lochhead J, Satchi K, et al. Bilateral retinal venous occlusion and unilateral cystoid macular edema in Churg-Strauss syndrome treated with intravitreal triamcinolone. Retina 2005;25:655-657.
101. Salinas-Alamán A, Garci'a-Layana A, Sa'daba-Echarri LM, Belzunce-Manterola A. Branch retinal vein occlusion treated by intravitreal triamcinolone. Arch Soc Esp Oftalmol 2005;80:463-465.
102. Lee H, Shah GK. Intravitreal triamcinolone as primary treatment of cystoid macular edema secondary to branch retinal vein occlusion. Retina 2005;25:551-555.
103. Hayashi K, Hayashi H. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2005; 139:972-982.
104. Ozkiris A, Evereklioglu C, Erkiliç K, Ilhan O. The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion. Eur J Ophthalmol 2005;15: 96-101.
105. Jonas JB, Akkoyun I, Kamppeter B, et al. Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye 2005;19:65-71.
106. Tsujikawa A, Fujihara M, Iwawaki T, et al. Triamcinolone acetonide with vitrectomy for treatment of macular edema associated with branch retinal vein occlusion. Retina 2005;25:861-867.
107. Karacorlu M, Ozdemir H, Karacorlu SA. Resolution of serous macular detachment after intravitreal triamcinolone acetonide treatment of patients with branch retinal vein occlusion. Retina 2005;25:856-860.
108. Cekiç O, Chang S, Tseng JJ, et al. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina 2005;25:851-855.
109. Avitabile T, Longo A, Reibaldi A. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol 2005;140:695-702.
110. Krepler K, Ergun E, Sacu S, et al. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: A pilot study. Acta Ophthalmol Scand 2005;83:600-604.
111. Tewari HK, Sony P, Chawla R, et al. Prospective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disorders. Eur J Ophthalmol 2005;15:619-626.
112. Ozkiris A, Evereklioglu C, Erkilic K, Dogan H. Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion. Eye 2006;20: 13-17.
113. Cheng KC, Wu WC. Intravitreal triamcinolone acetonide for patients with macular edema due to branch retinal vein occlusion. Kaohsiung J Med Sci 2006;22:321-330.
114. Oh JY, Seo JH, Ahn JK, et al. Early versus late intravitreal triamcinolone acetonide for macular edema associated with branch retinal vein occlusion. Korean J Ophthalmol 2007;21:18-20.
115. Cakir M, Dogan M, Bayraktar Z, et al. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation. Retina 2008; 28:465-472.
116. Patel PJ, Zaheer I, Karia N. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion. Eye 2008;22:60-64.
117. Ozdek S, Deren YT, Gurelik G, Hasanreisoglu B. Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion. Ophthalmic Res 2008;40:26-31.
118. Ramezani A, Entezari M, Moradian S, et al. Intravitreal triamcinolone for acute branch retinal vein occlusion: a randomized clinical trial. J Ophthalmic Vis Res 2011;6: 101-108.
119. Seymenoǧlu G, Kayikçioǧlu O, Sahin BÖ. Resolution of vitreomacular traction following intravitreal triamcinolone acetonide injection in an eye with branch retinal vein occlusion. Clin Ophthalmol 2012;6:1239-1243.
120. Noma H, Funatsu H, Mimura T, Shimada K. Functionalmorphological changes after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion. J Ocul Pharmacol Ther 2012;28: 231-236.
121. Kawaji T, Hirata A, Awai N, et al. Trans-tenon retrobulbar triamcinolone injection for macular edema associated with branch retinal vein occlusion remaining after vitrectomy. Am J Ophthalmol 2005;140:540-542.
122. Parodi MB, Iacono P, Ravalico G. Intravitreal triamcinolone acetonide combined with subthreshold grid laser treatment for macular oedema in branch retinal vein occlusion: A pilot study. Br J Ophthalmol 2008;92: 1046-1050.
123. Riese J, Loukopoulos V, Meier C, et al. Combined intravitreal triamcinolone injection and laser photocoagulation in eyes with persistent macular edema after branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2008;246:1671-1676.
124. Hayashi A, Yunoki T, Miyakoshi A, et al. Intravitreal injection of bevacizumab combined with macular grid laser photocoagulation for macular edema in branch retinal vein occlusion. Jpn J Ophthalmol 2011;55:625-631.
125. Ehrlich R, Ciulla TA, Moss AM, Harris A. Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up. Graefes Arch Clin Exp Ophthalmol 2010;248:375-380.
126. Robinson MR, Whitcup SM. Pharmacologic and clinical profile of dexamethasone intravitreal implant. Expert Rev Clin Pharmacol 2012;5:629-647.
127. Haller JA, Bandello F, Belfort Jr R, et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010;117:1134-1146.
128. Haller JA, Bandello F, Belfort Jr R, et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 2011;118: 2453-2460.
129. Coscas G, Coscas F, Zucchiatti I, et al. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex-. Eur J Ophthalmol 2011;21:631-636.
130. Moisseiev E, Goldstein M, Waisbourd M, et al. Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion. Eye 2013;27:65-71.
131. Yeh WS, Haller JA, Lanzetta P, et al. Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. Ophthalmology 2012;119:1190-1198.
132. Mayer WJ, Remy M, Wolf A, et al. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema. Ophthalmologica 2012;228:110-116.
133. Singer MA, Bell DJ, Woods P, et al. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion. Retina 2012;32:1289-1294.
134. Gragoudas ES, Adamis AP, Cunningham Jr ET, et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-2816.
135. Sultan MB, Zhou D, Loftus J, et al. A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema. Ophthalmology 2011;118:1107-1118.
136. Gonza'lez VH, Giuliari GP, Banda RM, Guel DA. Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy. Br J Ophthalmol 2009;93: 1474-1478.
137. Adamis AP, Altaweel M, Bressler NM, et al. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology 2006;113: 23-28.
138. Wroblewski JJ, Wells JA, Adamis AP, et al. Pegaptanib sodium for macular edema secondary to central retinal vein occlusion. Arch Ophthalmol 2009;127:374-380.
139. Wroblewski JJ, Wells 3rd JA, Gonzales CR. Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion. Am J Ophthalmol 2010;149:147-154.
140. Wong I, Koo S, Chan C. Pegaptanib for branch retinal vein occlusion. Am J Ophthalmol 2010;150:129.
141. Gallego-Pinazo R, Francés E, Gómez MJ, et al. Initial and unique treatment of macular edema due to branch retinal vein occlusion with antiangiogenic agents: A comparative pilot study. Arch Soc Esp Oftalmol 2009;84:229-230.
142. Udaondo P, Garcia-Delpech S, Salom D, et al. Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion. Clin Ophthalmol 2011;5:941-944.
143. Wu L, Arevalo JF, Berrocal MH, et al. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: Results of the Pan American Collaborative Retina Study Group at 24 months. Retina 2009;29: 1396-1403.
144. Ahmadieh H, Moradian S, Malihi M. Rapid regression of extensive retinovitreal neovascularization secondary to branch retinal vein occlusion after a single intravitreal injection of bevacizumab. Int Ophthalmol 2005;26:191-193.
145. Jaissle GB, Ziemssen F, Petermeier K, et al. Bevacizumab for treatment of macular edema secondary to retinal vein occlusion. Ophthalmologe 2006;103:471-475.
146. Spandau U, Wickenhäuser A, Rensch F, Jonas J. Intravitreal bevacizumab for branch retinal vein occlusion. Acta Ophthalmol Scand 2007;85:118-119.
147. Pai SA, Shetty R, Vijayan PB, et al. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol 2007;143:601-606.
148. Schaal KB, Ho?h AE, Scheuerle A, et al. Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Ophthalmologe 2007;104:285-289.
149. Stahl A, Agostini H, Hansen LL, Feltgen N. Bevacizumab in retinal vein occlusion: Results of a prospective case series. Graefes Arch Clin Exp Ophthalmol 2007;245: 1429-1436.
150. Rabena MD, Pieramici DJ, Castellarin AA, et al. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 2007;27:419-425.
151. Kreutzer TC, Alge CS, Wolf AH, et al. Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 2008;92:351-355.
152. Kriechbaum K, Michels S, Prager F, et al. Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: A prospective study. Br J Ophthalmol 2008;92: 518-522.
153. Gündü z K, Bakri SJ. Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion. Eye 2008;22:1168-1171.
154. Wu L, Arevalo JF, Roca JA, et al. Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: Results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up. Retina 2008;28: 212-219.
155. Chalam KV, Keshavamurthy R, Brar VS. Spectral domain OCT documented resolution of recalcitrant macular edema after intravitreal bevacizumab in branch retinal vein occlusion. Eur J Ophthalmol 2008;18:831-833.
156. Abegg M, Tappeiner C, Wolf-Schnurrbusch U, et al. Treatment of branch retinal vein occlusion induced macular edema with bevacizumab. BMC Ophthalmol 2008;8:18.
157. Chung EJ, Hong YT, Lee SC, et al. Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2008;246:1241-1247.
158. Rensch F, Jonas JB, Spandau UH. Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion. Ophthalmologica 2009;223:124-127.
159. Jaissle GB, Leitritz M, Gelisken F, et al. One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2009;247:27-33.
160. Prager F, Michels S, Kriechbaum K, et al. Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol 2009;93:452-456.
161. Ahmadi AA, Chuo JY, Banashkevich A, et al. The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion. Can J Ophthalmol 2009;44:154-159.
162. Gregori NZ, Rattan GH, Rosenfeld PJ, et al. Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion. Retina 2009;29:913-925.
163. Yamauchi Y, Mori F, Masahara H, et al. Use of intravitreal bevacizumab for macular edema in branch retinal vein occlusion. Nihon Ganka Gakkai Zasshi 2009;113:672-674.
164. Hoeh AE, Ach T, Schaal KB, et al. Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2009;247:1635-1641.
165. Gutiérrez JC, Barquet LA, Caminal JM, et al. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion. Clin Ophthalmol 2008; 2:787-791.
166. Kondo M, Kondo N, Ito Y, et al. Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion: Results after 12 months and multiple regression analysis. Retina 2009;29:1242-1248.
167. Figueroa MS, Contreras I, Noval S, Arruabarrena C. Results of bevacizumab as the primary treatment for retinal vein occlusions. Br J Ophthalmol 2010;94:1052-1056.
168. Hara S, Sakuraba T, Kataoka H, et al. Effect of repeated intravitreal
169. Lim JW. Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion. Ophthalmologica 2011;225:150-154.
170. Ehlers JP, Decroos FC, Fekrat S. Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion. Retina 2011;31:1856-1862.
171. Demir M, Oba E, Gulkilik G, et al. Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results. Clin Ophthalmol 2011;5: 745-749.
172. Yunoki T, Miyakoshi A, Nakamura T, et al. Treatment of macular edema due to branch retinal vein occlusion with single or multiple intravitreal injections of bevacizumab. Jpn J Ophthalmol 2012;56:159-164.
173. Thapa R, Maharjan N, Paudyal G. Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results. Clin Ophthalmol 2012;6: 1057-1062.
174. Preti RC, Ramirez LM, Pimentel SL, et al. Single intravitreal bevacizumab injection effects on contrast sensitivity in macular edema from branch retinal vein occlusion. Arq Bras Oftalmol 2012;75:29-32.
175. Siegel RA, Dreznik A, Mimouni K, et al. Intravitreal bevacizumab treatment for macular edema due to branch retinal vein occlusion in a clinical setting. Curr Eye Res 2012;37:823-829.
176. Kang HM, Chung EJ, Kim YM, Koh HJ. Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2013;251:501-508.
177. Park S, Cho IH, Park TK, et al. Extrafoveal changes following intravitreal bevacizumab injections for macular edema secondary to branch retinal vein occlusion: An mfERG and OCT study. Doc Ophthalmol 2013;126:137-148.
178. Matsumoto Y, Freund KB, Peiretti E, et al. Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina 2007;27: 426-431.
179. Campa C, D'Angelo S, Incorvaia C. Comment of article by Matsumoto Y. Retina 2008;28:782.
180. Deka S, Kalita K, Singh SK. Rebound effect following intravitreal bevacizumab in branch retinal vein occlusion. Oman J Ophthalmol 2009;2:94-95.
181. Yasuda S, Kondo M, Kachi S, et al. Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion. Retina 2011;31:1075-1082.
182. Hanada N, Iijima H, Sakurada Y, Imasawa M. Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab. Jpn J Ophthalmol 2012;56:165-174.
183. Hayashi A, Yunoki T, Miyakoshi A, et al. Intravitreal injection of bevacizumab combined with macular grid laser photocoagulation for macular edema in branch retinal vein occlusion. Jpn J Ophthalmol 2011;55: 625-631.
184. Donati S, Barosi P, Bianchi M, et al. Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion. Eur J Ophthalmol 2012;22:607-614.
185. Ogino K, Tsujikawa A, Murakami T, et al. Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion. Clin Ophthalmol 2011;5:1031-1036.
186. Salinas-Alamán A, Zarranz-Ventura J, Caire González- Jauregui JM, et al. Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion. Eur J Ophthalmol 2011;21:434-439.
187. Russo V, Barone A, Conte E, et al. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion. Retina 2009;29:511-515.
188. Parveen S, Narayanan R, Sambhav K, Bhatia K. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion. Retina 2010;30:1324-1325; author reply 1325.
189. Leitritz MA, Gelisken F, Ziemssen F, et al. Grid laser photocoagulation for macular oedema due to branch retinal vein occlusion in the age of bevacizumab? Results of a prospective study with crossover design. Br J Ophthalmol 2013;97:215-219.
190. Kelkar AS, Sayyad MG, Kelkar JA, et al. Comparison of single injection of intravitreal triamcinolone versus single injection of intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusions with regard to changes in best corrected visual acuity and central macular thickness in the short term. Indian J Ophthalmol 2009;57:243-244.
191. Kim JY, Park SP. Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion. Korean J Ophthalmol 2009;23:259-265.
192. Hou J, Tao Y, Jiang YR, et al. Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: A matched study. Chin Med J 2009;122:2695-2699.
193. Cheng KC, Wu WC, Chen KJ. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion. Eye 2009;23:2023-2033.
194. Chen CH, Chen YH, Wu PC, et al. Treatment of branch retinal vein occlusion induced macular edema in treatment- nai?ve cases with a single intravitreal triamcinolone or bevacizumab injection. Chang Gung Med J 2010;33: 424-435.
195. Guthoff R, Meigen T, Hennemann K, Schrader W. Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in a pair-matched analysis. Ophthalmologica 2010;224:319-324.
196. Byun YJ, Roh MI, Lee SC, Koh HJ. Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2010;248: 963-971.
197. Cekiç O, Cakir M, Yazici AT, et al. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. Curr Eye Res 2010;35:925-929.
198. Higashiyama T, Sawada O, Kakinoki M, et al. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion. Acta Ophthalmol 2013;91:318-324.
199. Ramezani A, Esfandiari H, Entezari M, et al. Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent-onset branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2012;250: 1149-1160.
200. Campochiaro PA, Hafiz G, Shah SM, et al. Ranibizumab for macular edema due to retinal vein occlusions: Implication of VEGF as a critical stimulator. Mol Ther 2008;16:791-799.
201. Gallego-Pinazo R, Francés E, Gómez MJ, et al. Initial and unique treatment of macular edema due to branch retinal vein occlusion with antiangiogenic agents: A comparative pilot study. Arch Soc Esp Oftalmol 2009; 84:229-230.
202. Campochiaro PA, Hafiz G, Channa R, et al. Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: Two-year outcomes. Ophthalmology 2010;117:2387-2394.
203. Campochiaro PA, Heier JS, Feiner L, et al. Ranibizumab for macular edema following branch retinal vein occlusion: Six-month primary end point results of a phase III study. Ophthalmology 2010;117:1102-1112.
204. Rouvas A, Petrou P, Ntouraki A, et al. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion- induced macular edema: Nine-month results of a prospective study. Retina 2010;30:893-902.
205. Pece A, Isola V, Piermarocchi S, Calori G. Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for naive retinal vein occlusion: 1-year follow-up. Br J Ophthalmol 2011;95:56-68.
206. Brown DM, Campochiaro PA, Bhisitkul RB, et al. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology 2011;118: 1594-1602.
207. Azad R, Vivek K, Sharma Y, et al. Ranibizumab as an adjunct to laser for macular edema secondary to branch retinal vein occlusion. Indian J Ophthalmol 2012;60: 263-266.
208. Puche N, Glacet A, Mimoun G, et al. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes. Acta Ophthalmol 2012;90:357-361.
209. Kim M, Yu SY, Kim ES, et al. Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion. Ophthalmologica 2012;227:132-138.
210. Heier JS, Campochiaro PA, Yau L, et al. Ranibizumab for macular edema due to retinal vein occlusions: Long-term follow-up in the HORIZON trial. Ophthalmology 2012;119: 802-809.
211. Varma R, Bressler NM, Suñer I, et al. Improved visionrelated function after ranibizumab for macular edema after retinal vein occlusion: Results from the BRAVO and CRUISE trials. Ophthalmology 2012;119:2108-2118.
212. Karagiannis DA, Karampelas MD, Soumplis VM, et al. Recurrence of macular edema in retinal vein occlusions after treatment with intravitreal ranibizumab (Lucentis). Can J Ophthalmol 2011;46:486-490.